Throughout 2015, AmeriHealth has been updating various aspects of our Direct
Ship Drug Program. This program is a value-added service that allows our
network providers to order select office-based drugs covered under the medical
benefit without incurring cost. AmeriHealth works directly with our contracted
specialty drug vendors to handle processing, payment, and delivery.
Some of our recent improvements to the program include:
-
updating our website to highlight the advantages of the Direct Ship Drug
Program;
-
creating a downloadable list of all the drugs available through the program;
-
facilitating delivery of select infusion drugs like infliximab
(Remicade®).
Recent changes
Two additional changes were recently made to the program:
-
Updated order forms. The Direct Ship Drug Program order forms have been updated
to align with current medical policy coverage criteria and to remove ICD-9
coding options, which are obsolete as of October 1, 2015, when ICD-10 goes into
effect. To avoid processing delays, providers must use the updated Direct Ship
Drug Program order forms starting October 1, 2015. As a reminder, providers
must report the ICD-10 code that is most specific to the member's diagnosis.
-
Dedicated fax line. In order to increase processing efficiency, AmeriHealth has
created a dedicated fax line for all Direct Ship Drug Program requests.
Completed order forms should be faxed to 215-761-9580. This number is also
printed at the bottom of the order forms.
Due to the nature of these changes, AmeriHealth is asking providers to
immediately discard any copies of the old Direct Ship Drug Program order forms.
Updated forms are available at the Direct Ship Drug Program websites for
AmeriHealth New Jersey and
AmeriHealth
Pennsylvania.